{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:52Z","timestamp":1791999172030,"version":"4.4.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0012693","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000}}],"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2015-02499, 2020-01365"],"award-info":[{"award-number":["2015-02499, 2020-01365"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r Strategisk Forskning","doi-asserted-by":"publisher","award":["SB12-0003"],"award-info":[{"award-number":["SB12-0003"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region Stockholm","award":["CIMED 2020-2022"],"award-info":[{"award-number":["CIMED 2020-2022"]}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec021\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Flavivirus infections pose a significant global health burden, highlighting the need for safe and effective vaccination strategies. Co-administration of different vaccines, including licensed flavivirus vaccines, is commonly practiced providing protection against multiple pathogens while also saving time and reducing visits to healthcare units. However, how co-administration of different flavivirus vaccines\n                      <jats:italic>de facto<\/jats:italic>\n                      affects immunogenicity, particularly with respect to T cell responses, is only partially understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec022\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>Antigen-specific T cell responses were assessed in study participants enrolled in a previously conducted open-label, non-randomized clinical trial. In the trial, vaccines against tick-borne encephalitis virus (TBEV), Japanese encephalitis virus (JEV), or yellow fever virus (YFV) were administered either individually or concomitantly in different combinations in healthy study participants. Peripheral blood samples were collected before vaccination and at multiple time points afterward. To analyze antigen-specific CD4+ and CD8+ T cell responses, PBMCs were stimulated with overlapping peptide pools from TBEV, JEV, YFV, and Zika virus (ZIKV) envelope (E), capsid (C), and non-structural protein 5 (NS5) viral antigens. A flow cytometry-based activation-induced marker (AIM) assay was used to quantify antigen-specific T cell responses. The results revealed remarkably similar frequencies of CD4+ and CD8+ T cell responses, regardless of whether vaccines were administered individually or concomitantly. In addition, administering the vaccines in the same or different upper arms did not markedly affect T cell responses. Finally, limited cross-reactivity was observed between the TBEV, JEV, and YFV vaccines, and related ZIKV-specific antigens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec023\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TBEV or JEV vaccines can be co-administered with the live attenuated YFV vaccine without any markedly altered antigen-specific CD4+ and CD8+ T cell responses to the respective flaviviruses. Additionally, the vaccines can be delivered in the same or different upper arms without any significant altered influence on the T cell response. From a broader perspective, these results provide valuable insights into the outcome of immune responses following simultaneous administration of different vaccines for different but related pathogens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0012693","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:21:13Z","timestamp":1740748873000},"page":"e0012693","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-0394","authenticated-orcid":true,"given":"David","family":"Wullimann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Tyler","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Akber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"L\u00f6fling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gredmark-Russ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Micha\u00eblsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Buggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0908-7387","authenticated-orcid":true,"given":"Hans-Gustaf","family":"Ljunggren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"1","key":"pntd.0012693.ref001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV Virus Taxonomy Profile: Flaviviridae","volume":"98","author":"P Simmonds","year":"2017","journal-title":"J Gen Virol"},{"key":"pntd.0012693.ref002","unstructured":"World Health Organization. Yellow Fever 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever"},{"key":"pntd.0012693.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.01.004","article-title":"Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment","volume":"62","author":"N Riccardi","year":"2019","journal-title":"Eur J Intern Med"},{"key":"pntd.0012693.ref004","first-page":"435","article-title":"Epidemiology of Japanese encephalitis: past, present, and future prospects","volume":"11","author":"H Wang","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"pntd.0012693.ref005","doi-asserted-by":"crossref","first-page":"197770","DOI":"10.1016\/j.virusres.2019.197770","article-title":"Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis","volume":"274","author":"HY Chong","year":"2019","journal-title":"Virus Res"},{"issue":"6","key":"pntd.0012693.ref006","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"TC Pierson","year":"2020","journal-title":"Nat Microbiol"},{"key":"pntd.0012693.ref007","doi-asserted-by":"crossref","first-page":"101305","DOI":"10.1016\/j.coviro.2023.101305","article-title":"Flavivirus nonstructural proteins and replication complexes as antiviral drug targets","volume":"59","author":"K van den Elsen","year":"2023","journal-title":"Curr Opin Virol"},{"issue":"9","key":"pntd.0012693.ref008","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41577-024-01016-6","article-title":"Generating prophylactic immunity against arboviruses in vertebrates and invertebrates","volume":"24","author":"DJ Rawle","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"29","key":"pntd.0012693.ref009","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"FX Heinz","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"pntd.0012693.ref010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/v15040860","article-title":"A Perspective on Current Flavivirus Vaccine Development: A Brief Review","volume":"15","author":"SK Dutta","year":"2023","journal-title":"Viruses"},{"key":"pntd.0012693.ref011","unstructured":"Orenstein WA, Offit PA, Edwards KM, Plotkin SA. Plotkin\u2019s vaccines. 8th edition. ed. Philadelphia, PA: Elsevier; 2024. xxiii, 1782 pages p."},{"issue":"2","key":"pntd.0012693.ref012","doi-asserted-by":"crossref","first-page":"e0010616","DOI":"10.1371\/journal.pntd.0010616","article-title":"Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial","volume":"17","author":"JT Sandberg","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pntd.0012693.ref013","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses","volume":"19","author":"JL Slon Campos","year":"2018","journal-title":"Nat Immunol"},{"key":"pntd.0012693.ref014","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"F Sievers","year":"2011","journal-title":"Mol Syst Biol"},{"issue":"64","key":"pntd.0012693.ref015","doi-asserted-by":"crossref","first-page":"eabk0894","DOI":"10.1126\/sciimmunol.abk0894","article-title":"Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue","volume":"6","author":"J Niessl","year":"2021","journal-title":"Sci Immunol"},{"issue":"16","key":"pntd.0012693.ref016","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/bioinformatics\/btw191","article-title":"flowAI: automatic and interactive anomaly discerning tools for flow cytometry data","volume":"32","author":"G Monaco","year":"2016","journal-title":"Bioinformatics"},{"issue":"11","key":"pntd.0012693.ref017","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41577-024-01040-6","article-title":"A guide to adaptive immune memory","volume":"24","author":"N Lam","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"pntd.0012693.ref018","unstructured":"Vaccine Recommendations and Guidelines of the ACIP 2024. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/timing.html."},{"issue":"12","key":"pntd.0012693.ref019","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"RS Akondy","year":"2009","journal-title":"J Immunol"},{"issue":"23","key":"pntd.0012693.ref020","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1128\/JVI.01160-13","article-title":"Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins","volume":"87","author":"EA James","year":"2013","journal-title":"J Virol"},{"issue":"11","key":"pntd.0012693.ref021","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/v12111300","article-title":"Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees","volume":"12","author":"J Mateus","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"pntd.0012693.ref022","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4049\/jimmunol.1901115","article-title":"Magnitude and Functional Profile of the Human CD4+ T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus Vaccine","volume":"204","author":"R Varnait\u0117","year":"2020","journal-title":"J Immunol"},{"issue":"14","key":"pntd.0012693.ref023","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1128\/JVI.00196-14","article-title":"Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction","volume":"88","author":"J Schwaiger","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"pntd.0012693.ref024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41541-024-00936-7","article-title":"Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins","volume":"9","author":"A Aregay","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"7","key":"pntd.0012693.ref025","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.20151517","article-title":"Human T cell responses to Japanese encephalitis virus in health and disease","volume":"213","author":"L Turtle","year":"2016","journal-title":"J Exp Med"},{"issue":"1","key":"pntd.0012693.ref026","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12985-021-01611-2","article-title":"The key amino acids of E protein involved in early flavivirus infection: viral entry","volume":"18","author":"T Hu","year":"2021","journal-title":"Virol J"},{"issue":"46","key":"pntd.0012693.ref027","doi-asserted-by":"crossref","first-page":"46007","DOI":"10.1074\/jbc.M307776200","article-title":"Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein","volume":"278","author":"K-P Wu","year":"2003","journal-title":"J Biol Chem"},{"key":"pntd.0012693.ref028","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2018.09.020","article-title":"CD4 T cell responses to flaviviruses","volume":"108","author":"JH Aberle","year":"2018","journal-title":"J Clin Virol"},{"issue":"2","key":"pntd.0012693.ref029","doi-asserted-by":"crossref","first-page":"e0008034","DOI":"10.1371\/journal.pntd.0008034","article-title":"Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans","volume":"14","author":"S Malafa","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0012693.ref030","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41467-024-45806-x","article-title":"Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection","volume":"15","author":"A Santos-Peral","year":"2024","journal-title":"Nat Commun"},{"key":"pntd.0012693.ref031","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-019-0133-5","article-title":"Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination","volume":"4","author":"V Bradt","year":"2019","journal-title":"NPJ Vaccines"},{"issue":"3","key":"pntd.0012693.ref032","doi-asserted-by":"crossref","first-page":"e0011124","DOI":"10.1371\/journal.pntd.0011124","article-title":"Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study","volume":"17","author":"V Tricou","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0012693.ref033","doi-asserted-by":"crossref","first-page":"e1214","DOI":"10.1093\/infdis\/jiae222","article-title":"Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination","volume":"230","author":"C Sirivichayakul","year":"2024","journal-title":"J Infect Dis"},{"issue":"9","key":"pntd.0012693.ref034","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/infdis\/jiab185","article-title":"Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans","volume":"224","author":"KE Burgomaster","year":"2021","journal-title":"J Infect Dis"},{"key":"pntd.0012693.ref035","doi-asserted-by":"crossref","first-page":"104815","DOI":"10.1016\/j.ebiom.2023.104815","article-title":"Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine","volume":"97","author":"Y Li","year":"2023","journal-title":"EBioMedicine"},{"issue":"11","key":"pntd.0012693.ref036","doi-asserted-by":"crossref","first-page":"e29245","DOI":"10.1002\/jmv.29245","article-title":"Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick-borne encephalitis and dengue virus infections","volume":"95","author":"L Ro\u00dfbacher","year":"2023","journal-title":"J Med Virol"},{"issue":"7","key":"pntd.0012693.ref037","doi-asserted-by":"crossref","first-page":"eaar4297","DOI":"10.1126\/sciadv.aar4297","article-title":"Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells","volume":"4","author":"WAA Saron","year":"2018","journal-title":"Sci Adv"},{"issue":"11","key":"pntd.0012693.ref038","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4161\/hv.6.11.12854","article-title":"Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity","volume":"6","author":"PE Nasveld","year":"2010","journal-title":"Hum Vaccin"},{"key":"pntd.0012693.ref039","doi-asserted-by":"crossref","first-page":"640190","DOI":"10.3389\/fimmu.2021.640190","article-title":"Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine","volume":"12","author":"NS Lima","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"pntd.0012693.ref040","doi-asserted-by":"crossref","first-page":"e00089-20","DOI":"10.1128\/JVI.00089-20","article-title":"T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species","volume":"94","author":"A Grifoni","year":"2020","journal-title":"J Virol"},{"key":"pntd.0012693.ref041","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3389\/fimmu.2019.02260","article-title":"Seeking Flavivirus Cross-Protective Immunity","volume":"10","author":"L Dos Santos Franco","year":"2019","journal-title":"Front Immunol"},{"issue":"11","key":"pntd.0012693.ref042","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/v15112244","article-title":"Does the Presence or a High Titer of Yellow Fever Virus Antibodies Interfere with Pregnancy Outcomes in Women with Zika Virus Infection?","volume":"15","author":"ICR Piauilino","year":"2023","journal-title":"Viruses"},{"issue":"3","key":"pntd.0012693.ref043","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/joim.12638","article-title":"Prospects for induction of CD8 T cell-mediated immunity to Zika virus infection by yellow fever virus vaccination","volume":"282","author":"K Blom","year":"2017","journal-title":"J Intern Med"},{"key":"pntd.0012693.ref044","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fimmu.2020.00334","article-title":"Cross-Reactive Immunity Among Flaviviruses","volume":"11","author":"APS Rathore","year":"2020","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0012693","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T16:09:29Z","timestamp":1741622969000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012693"}},"subtitle":[],"editor":[{"given":"Alexander","family":"Bukreyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012693","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.14.24317320","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}